28 janv. 2026
LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES
LSL Pharma FDA approved!
Groupe LSL approuvé FDA!
6 janv. 2026
Juno OTC acquisition & 10 M$ brokered offering
